China SXT Pharmaceuticals Inc (NASDAQ:SXTC) saw a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 142,300 shares, a decrease of 49.0% from the July 31st total of 278,900 shares. Based on an average daily trading volume, of 40,800 shares, the days-to-cover ratio is presently 3.5 days. Currently, 1.7% of the company’s shares are sold short.

NASDAQ SXTC traded up $0.09 during trading hours on Wednesday, reaching $2.36. The company had a trading volume of 85,200 shares, compared to its average volume of 161,185. The stock has a 50-day moving average of $2.44 and a 200 day moving average of $4.21. China SXT Pharmaceuticals has a 1-year low of $1.97 and a 1-year high of $23.35.

Several institutional investors and hedge funds have recently made changes to their positions in SXTC. Spark Investment Management LLC purchased a new stake in shares of China SXT Pharmaceuticals in the 1st quarter valued at approximately $94,000. Invesco Ltd. acquired a new position in shares of China SXT Pharmaceuticals in the 2nd quarter worth approximately $88,000. Finally, Jane Street Group LLC purchased a new position in shares of China SXT Pharmaceuticals during the 2nd quarter worth approximately $72,000. Institutional investors and hedge funds own 7.67% of the company’s stock.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives.

Recommended Story: What is required to own or exchange cryptocurrency?

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with's FREE daily email newsletter.